Abstract
Background Although magnesium (Mg) has been proposed as a useful biomarker for predicting atherothrombosis, the association between Mg and acute stent thrombosis (ST) after primary percutaneous coronary intervention (p-PCI) for ST-segment elevation myocardial infarction (STEMI) has not yet been defined. Objectives We aimed to examine whether admission Mg levels predicted the development of acute ST after p-PCI in STEMI patients. Methods and results A total of 2633 patients with STEMI who underwent p-PCI were retrospectively analyzed. Acute ST was defined as thrombosis that occurred in the first (0–1) days following primary coronary stenting, and patients who had undergone p-PCI were divided into two groups: ST group and no-ST group. The cut-off value for Mg obtained by the receiver-operating characteristic curve analysis was less than 1.91 mg/dl for the prediction of acute ST (area under the curve was 0.761; 95% confidence interval, 0.706–0.816; PPP<0.001). Conclusion Serum Mg level is associated independently with the risk of acute ST in patients with STEMI who undergo p-PCI.

This publication has 31 references indexed in Scilit: